Healthcare and Life Science
New Certified Climate Change Training
In conjunction with The Carbon Literacy project we are offering individuals from all sectors the opportunity to be certified as Carbon Literate by attending our course on 7 November 2022. ...
More about prenatal Physical Activity
A supervised prenatal Physical Activity can be started after the 3rd month and after a medical check-up. ...
CIIPM Training - new autumn training courses
CIIPM returns to in-person training for 4 half-day courses in IP&Commercialisation and Freedom to Operate searching ...
Results from EBCam's Employee Benefits and Rewards Survey released
Local employee benefit specialists and financial advisers EBCam Ltd share the results from their first annual employee benefit and reward survey. EBCam launched an employee benefits and rewards survey earlier this year and invited local businesses to take part to aid them in benchmarki...
H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support
Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research. ...
PhoreMost enters multi-project drug target discovery collaboration with Roche
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes. ...
Guardtech going for gold at four awards evenings in space of four months
The cleanroom construction Group are up for five honours at glitzy showpieces in London and Cambridgeshire. ...
Avacta announces AVA6000 receives Orphan Drug Designation from the US Food and Drug Administration
London and Wetherby, UK - Avacta Group plc, a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to...
Global Access Diagnostics acquires manufacturing rights for IT-LEISH rapid diagnostic test from Bio-Rad Laboratories
Bedford, UK - Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, announces it has acquired the manufacturing rights for the IT-LEISH rapid diagnostic test (RDT) for visceral leishmaniasis (VL) from Bio...